By Dr Nicky Keay, Honorary Clinical Lecturer, Division of Medicine, UCL
The collaboration is hoped to expand access to important, reliable fertility tests
The giant's big-selling contraceptive has been approved in Europe to provide up to eight years of pregnancy protection
Ovaprene could become the first FDA-approved monthly, self-administered, hormone-free contraceptive product
As the global IVF market is estimated to reach US$36.2b by 2026, embryologist Cynthia Hudson tells FemTech World why IVF has become the logical response when...
Ireland's Women’s Health Fund aims to drive research, innovation and support for women in at-risk populations
The platform is hoped to integrate new technologies and improve customer experience
Flo strengthens data protection in an effort to protect sensitive reproductive health information
The women’s health tracking app Flo has released its Anonymous Mode feature in an effort to further protect sensitive reproductive health information post Roe v Wade....
The femtech brand aims to transform women’s wellness in India
